Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

givingcapital.com

Total Raised

$17.9M

Investors Count

2

GivingCapital Funding, GivingCapital Valuation & GivingCapital Revenue

4 Fundings

GivingCapital's latest funding round was a Acquired for on September 21, 2004.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/21/2004

Acquired

0

FY undefined

1

1/22/2002

Series B

$99M

0

FY undefined

10

10/10/2000

Series A

$99M

0

FY undefined

10

10/1/1999

Angel

$99M

0

FY undefined

10

Date

9/21/2004

1/22/2002

10/10/2000

10/1/1999

Round

Acquired

Series B

Series A

Angel

Amount

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

GivingCapital Investors

2 Investors

GivingCapital has 2 investors. Kintera invested in GivingCapital's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/21/2004

9/21/2004

1
Acquired

00/00/0000

00/00/0000

General Atlantic

Subscribe to see more

Growth Equity

Connecticut

First funding

9/21/2004

00/00/0000

Last Funding

9/21/2004

00/00/0000

Investor

General Atlantic

Rounds

1
Acquired

Subscribe to see more

Board Seats

Type

Growth Equity

Location

Connecticut

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.